This Week’s CGT News: Genethon’s Phase III Gene Therapy Trial
July 31, 2025
Our latest news roundup reports on Pierre Fabre’s FDA acceptance, CGT Catapult appointment, progress in Duchenne muscular dystrophy, and more.
4 min read
False
July 31, 2025
Our latest news roundup reports on Pierre Fabre’s FDA acceptance, CGT Catapult appointment, progress in Duchenne muscular dystrophy, and more.
4 min read
July 29, 2025
Vaccine is designed to clear pathological tau protein from the brain.
1 min read
By Stephanie Vine
July 28, 2025
Study shows that GLP-1 receptor agonists in type 2 diabetes patients offer protection against dementia.
3 min read
By Rob Coker
July 24, 2025
Our latest news roundup reports on Elevidys, CGT Catapult funding, a new Australia-based partnership, and more.
4 min read
By Rob Coker
July 18, 2025
Researchers at Roche-Genentech have found a way to help more antisense oligonucleotides reach their targets – by slowing things down inside cells.
3 min read
July 17, 2025
Our latest news roundup reports on Google DeepMind’s AlphaGenome launch, guidelines for improved stem cell donor selection, and more.
4 min read
By Stephanie Vine
July 16, 2025
Fungus linked to archeologists’ deaths shows early promise in leukemia.
2 min read
By Rob Coker
July 16, 2025
An Oxford University-led study has found that the Parkinson’s drug pramipexole might be just the dopamine boost that treatment-resistant depression has been waiting for.
3 min read
By Stephanie Vine
July 11, 2025
Researchers develop point-of-care device to produce personalized RNA medicines.
1 min read
July 10, 2025
Our latest news roundup reports on stem cells taking on diabetes, genome surgery centers, and more.
4 min read
False
False
False